✦ LIBER ✦

High-Dose Chemotherapy with Autologous Bone Marrow Support in Ovarian Carcinoma: The Bottom Line, More or Less

✍ Scribed by Tate Thigpen

Book ID: 115616540
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 207 KB
Volume: 57
Category: Article
ISSN: 0090-8258
DOI: 10.1006/gyno.1995.1142

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose alkylating agent chemotherapy

High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer

✍ Elizabeth J. Shpall; Daniel Clarke-Pearson; John T. Soper; Andrew Berchuck; Roy 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 639 KB

High-dose alkylating agent chemotherapy

High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer

✍ EJ Shpall; D Clarke-Pearson; JT Soper; A Berchuck; RB Jones; RC Bast Jr; M Ross; 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 138 KB

High-dose chemotherapy with autologous b

High-dose chemotherapy with autologous bone marrow support as consolidation after standard-dose adjuvant therapy in primary breast cancer patients with seven or more involved axillary lymph nodes

✍ Lalisang, R I; Hupperets, P S G J; ten Haaft, M A; Jansen, R L H; Schouten, H C 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 52 KB

Tandem high-dose chemotherapy with ifosf

Tandem high-dose chemotherapy with ifosfamide, carboplatin, and teniposide with autologous bone marrow transplantation for the treatment of poor prognosis common epithelial ovarian carcinoma

✍ Jean-Pierre Lotz; Carole Bouleuc; Thierry André; Emmanuel Touboul; Carmen Macove 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 975 KB

A Phase I or I1 trial was conducted to assess the toxicity and the efficacy of a tandem high dose chemotherapy combining ifosfamide, carboplatin, and teniposide in patients with poor prognosis ovarian carcinoma. ## METHODS. Thirtyseven patients were scheduled to receive tandem high dose therapy co

Feasibility and toxicity of high-dose ch

Feasibility and toxicity of high-dose chemotherapy with/without BCNU for autologous bone marrow transplantation (ABMT) in breast carcinoma

✍ Drakos, P; Nagler, A; Or, R; Naparstek, E; Kapelushnik, J; Slavin, S 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Salvage therapy with high-dose chemother

Salvage therapy with high-dose chemotherapy and autologous bone marrow support in the treatment of primary nonseminomatous mediastinal germ cell tumors

✍ E. R. Broun; C. R. Nichols; L. H. Einhorn; G. J. K. Tricot 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB 👁 2 views